Corteva Agriscience Announces U.S. EPA Registration of Enlist One® and Enlist Duo® Herbicides through 2029

WILMINGTON, Del., Jan. 11, 2022 /PRNewswire/ -- Corteva Agriscience is pleased to announce that the U.S. Environmental Protection Agency (EPA) has completed the registration amendment process for Enlist One^® and Enlist Duo^® herbicides, giving farmers certainty in product availability as they complete their 2022 seed planting and crop protection plans. Enlist herbicides received a seven-year registration through January 11, 2029.

The Enlist^® weed control system includes Enlist herbicides, Enlist™ Ahead, Enlist E3^® soybeans, Enlist^® cotton and Enlist corn. The comprehensive system offers multiple herbicide modes of action to control tough weeds and is centered around 2,4-D choline with Colex-D^® technology, which provides key benefits including near-zero volatility, reduced potential for off-target movement and physical drift, and improved handling characteristics. Further, Enlist cotton and Enlist E3 soybean crops are tolerant to three herbicide modes of action, 2,4-D, glufosinate and glyphosate, allowing for a robust integrated weed management program to tackle herbicide resistance and improve the sustainability of farmers' weed control practices.

"Farmers have been drawn to the technology's weed control results and flexible timing for use," said Susanne Wasson, president, Crop Protection Business Platform for Corteva Agriscience. "The on-target properties of the Enlist^® weed control system not only help protect rural neighbors but the updated label also increases protections for wildlife and habitats."

The Enlist herbicide registration amendment process included EPA conducting updated data analyses and initiating appropriate agency consultations to help confirm Enlist herbicides continue to comply with the Endangered Species Act (ESA), and the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA). As part of that process, EPA updated its ecological and ESA risk assessments, resulting in the addition of targeted risk mitigation measures to the Enlist herbicide labels. These updates will help ensure that use of Enlist herbicides in accordance with the label will help protect endangered species and their habitats while also allowing growers to continue to capture the benefits of the Enlist^® weed control system.

Corteva remains committed to grower education efforts – including in particular, education efforts focused on these label changes -- through its Enlist Ahead management resource, which informs growers, distributors, retailers and applicators about proper use. The Enlist Ahead program helps customers with on-target applications and sound weed management practices for successful, sustainable use of the Enlist^® weed control system. 

Enlist Ahead was launched with the Enlist system to provide farmers with the confidence they need to trust the system and achieve on-target herbicide applications. This winter, continued monthly webinars led by Enlist field specialists will provide information and answer questions about label changes and include guidance on subjects ranging from nozzle selection to tank-mix recommendations to neighbor-friendly characteristics of Enlist herbicides. From Oct. 2020 – Aug. 2021, more than 16,000 farmers, applicators and retailers were trained on how to use the system properly by attending webinars and other training opportunities.

"We're proud of our continued efforts to provide farmers and applicators with the tools they need to keep weeds at bay," said Cynthia Ericson, vice president, U.S. Marketing for Corteva Agriscience. "Enlist^® herbicides have been used successfully since 2017."

"As long as you stay on label and run the recommended rates, you'll have no problem keeping a clean field," says Ethan Clarke, Indiana farmer.

To learn more about the Enlist^® weed control system and see why farmers have made the switch, visit ExperiencingEnlist.com. Follow the Enlist system with @EnlistOnline on Twitter or go to the YouTube channel for latest updates and educational tips.

About Corteva Agriscience

Corteva, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry – including a balanced and diverse mix of seed, crop protection and digital solutions focused on maximizing productivity to enhance yield and profitability. With some of the most recognized brands in agriculture and an industry-leading product and technology pipeline well positioned to drive growth, the company is committed to working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva became an independent public company on June 1, 2019 and was previously the Agriculture Division of DowDuPont. More information can be found at www.corteva.com.

Follow Corteva Agriscience on Facebook, Instagram, LinkedIn, Twitter and YouTube.

#   #   #

^{™ ®} Trademarks of Corteva Agriscience and its affiliated companies. The transgenic soybean event in Enlist E3^® soybeans is jointly developed and owned by Corteva Agriscience and M.S. Technologies, L.L.C. Enlist Duo^® and Enlist One^® herbicides are not registered for sale or use in all states or counties. Contact your state pesticide regulatory agency to determine if a product is registered for sale or use in your area. Enlist Duo and Enlist One are the only 2,4-D products authorized for use with Enlist^™ crops. Consult Enlist herbicide labels for weed species controlled. Always read and follow label directions.

Cautionary Statement About Forward-Looking Statements

This communication contains forward-looking statements and other estimates within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements and other estimates contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like "guidance", "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates," "outlook," or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva's strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures, and financial results, as well as expected benefits from, the separation of Corteva from DowDuPont, are forward looking statements.

Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond Corteva's control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva's business, results of operations and financial condition. Some of the important factors that could cause Corteva's actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to obtain or maintain the necessary regulatory approvals for some Corteva's products; (ii) failure to successfully develop and commercialize Corteva's pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva's biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) effect of competition and consolidation in Corteva's industry; (vi) effect of competition from manufacturers of generic products; (vii) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (viii) effect of climate change and unpredictable seasonal and weather factors; (ix) risks related to oil and commodity markets; (x) competitor's establishment of an intermediary platform for distribution of Corteva's products; (xi) impact of Corteva's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xii) effect of industrial espionage and other disruptions to Corteva's supply chain, information technology or network systems; (xiii) effect of volatility in Corteva's input costs; (xiv) failure to realize the anticipated benefits of the internal reorganizations taken by DowDuPont in connection with the spin-off of Corteva and other cost savings initiatives; (xv) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xvi) failure of Corteva's customers to pay their debts to Corteva, including customer financing programs; (xvii) increases in pension and other post-employment benefit plan funding obligations; (xviii) risks related to the indemnification obligations of legacy EID liabilities in connection with the separation of Corteva; (xix) effect of compliance with laws and requirements and adverse judgments on litigation; (xx) risks related to Corteva's global operations; (xxi) failure to effectively manage acquisitions, divestitures, alliances and other portfolio actions; (xxii) risks related to COVID-19; (xxiii) risks related to activist stockholders; (xxiv) Corteva's intellectual property rights or defend against intellectual property claims asserted by others; (xxv) effect of counterfeit products; (xxvi) Corteva's dependence on intellectual property cross-license agreements; (xxvii) other risks related to the Separation from DowDuPont; (xxvii) risks related to the Biden executive order Promoting Competition in the American Economy; and (xxix) risks associated with our CEO transition. Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva's management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement or other estimate, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the "Risk Factors" section of Corteva's Annual Report on Form 10-K, as modified by subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K.

SOURCE Corteva, Inc.